Nitric oxide in the dorsal hippocampal area is involved on muscimol state-dependent memory in the step-down passive a...

A place to share academic research on Amantias.
Post Reply
User avatar
Amanita Research
Site Admin
Posts: 197
Joined: Tue Oct 01, 2019 7:44 pm
Has thanked: 143 times
Been thanked: 106 times

Nitric oxide in the dorsal hippocampal area is involved on muscimol state-dependent memory in the step-down passive a...

Post by Amanita Research » Sat Oct 05, 2019 7:16 pm

Title: Nitric oxide in the dorsal hippocampal area is involved on muscimol state-dependent memory in the step-down passive avoidance test
https://www.sciencedirect.com/science/a ... 5713003444

Abstract: In the present study, the effects of intra-dorsal hippocampal (intra-CA1) injections of nitric oxide (NO) agents on muscimol state-dependent memory were examined in mice. A single-trial step-down passive avoidance task was used for the assessment of memory retrieval in adult male NMRI mice.

Post-training intra-CA1 administration of a GABAA receptor agonist, muscimol (0.05 and 0.1 μg/mouse) dose dependently induced impairment of memory retention. Pre-test injection of muscimol (0.05 and 0.1 μg/mouse) induced state-dependent retrieval of the memory acquired under post-training muscimol (0.1 μg/mouse, intra-CA1) influence.

Pre-test injection of a NO precursor, l-arginine (1 and 2 μg/mouse, intra-CA1) improved memory retention, although the low dose of the drug (0.5 μg/mouse) did not affect memory retention.

Pre-test injection of an inhibitor of NO-synthase, l-NAME (0.5 and 1 μg/mouse, intra-CA1) impaired memory retention, although the low dose of the drug (0.25 μg/mouse) did not affect memory retention.

In other series of experiments, pre-test intra-CA1 injection of l-arginine (0.25 and 0.5 μg/mouse) 5 min before the administration of muscimol (0.1 μg/mouse, intra-CA1) dose dependently inhibited muscimol state-dependent memory. Pre-test intra-CA1 administration of l-arginine (0.125, 0.25 and 0.5 μg/mouse) by itself cannot affect memory retention.

Pre-test intra-CA1 injection of l-NAME (0.25 μg/mouse, intra-CA1) reversed the memory impairment induced by post-training administration of muscimol (0.1 μg/mouse, intra-CA1). Moreover, pre-test administration of l-NAME (0.125 and 0.25 μg/mouse, intra-CA1) with an ineffective dose of muscimol (0.025 μg/mouse, intra-CA1) significantly restored the retrieval and induced muscimol state-dependent memory. Pre-test intra-CA1 administration of l-NAME (0.0625, 0.125 and 0.25 μg/mouse) by itself cannot affect memory retention.

It may be suggested that the nitric oxide in the dorsal hippocampal area play an important role in muscimol state-dependent memory.

Post Reply